SCHEMBL23524935

SCHEMBL23524935

Cc1cc([N+](=O)[O-])c(Cl)cc1NC(=O)[C@H](C)N1CCOCC1

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.52
MAPT P10636 5/20 0.48
LMNA P02545 5/20 0.48
GAA P10253 4/20 0.48
KMT2A Q03164 4/20 0.48
POLB P06746 3/20 0.48
MEN1 O00255 3/20 0.48
KDM4E B2RXH2 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
MCL1 Q07820 1/20 0.48
AAK1 Q2M2I8 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.40
HTT P42858 2/20 0.40
TP53 P04637 1/20 0.40
GLA P06280 1/20 0.40
MAPK1 P28482 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ALOX12 P18054 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23524938 1.00 ALDH1A1 (0.52) ALDH1A1MAPTLMNAGAAKMT2A
SCHEMBL6533994 0.78 AAK1 (0.52) ALDH1A1MAPTGAAKMT2APOLB
SCHEMBL23524795 0.77 ALDH1A1 (0.40) ALDH1A1MAPTLMNAGAAKMT2A
SCHEMBL23524796 0.77 ALDH1A1 (0.40) ALDH1A1MAPTLMNAGAAKMT2A
SCHEMBL23567966 0.76 AAK1 (0.50) ALDH1A1MAPTLMNAGAAKMT2A
SCHEMBL23524981 0.74 AAK1 (0.47) ALDH1A1MAPTLMNAGAAKMT2A
SCHEMBL23524984 0.74 AAK1 (0.47) ALDH1A1MAPTLMNAGAAKMT2A
SCHEMBL2972082 0.73 SLC9A1 (0.60) ALDH1A1MAPTLMNAKMT2APOLB
SCHEMBL23525117 0.72 AAK1 (0.48) ALDH1A1MAPTLMNAKMT2AMEN1
SCHEMBL23525114 0.72 AAK1 (0.48) ALDH1A1MAPTLMNAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230280220-A1 Benzimidazole Derivative Compounds and Uses Thereof PFIZER INC. (US) 2023-09-07 US disclosed
US-20230280220-A1 Benzimidazole Derivative Compounds and Uses Thereof PFIZER INC. (US) 2023-09-07 US disclosed
US-11661419-B2 Benzimidazole derivative compounds and uses thereof PFIZER INC. (US) 2023-05-30 US disclosed
US-11661419-B2 Benzimidazole derivative compounds and uses thereof PFIZER INC. (US) 2023-05-30 US disclosed
US-20210188829-A1 Chemical Compounds PFIZER INC. (US) 2021-06-24 US disclosed
US-20210188829-A1 Chemical Compounds PFIZER INC. (US) 2021-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11661419-B2 Benzimidazole derivative compounds and uses thereof ITK, HRH4, BLK ALDH1A1 242/4885MAPT 2297/4885LMNA 3750/4885
US-20210188829-A1 Chemical Compounds ITK, HRH4, HRH1 ALDH1A1 167/4885MAPT 1663/4885LMNA 3955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.